Chemoinformaics analysis of L-AZETIDINE-2-CARBOXYLIC-ACID
| Molecular Weight | 101.105 | nRot | 1 |
| Heavy Atom Molecular Weight | 94.049 | nRig | 5 |
| Exact Molecular Weight | 101.048 | nRing | 1 |
| Solubility: LogS | -0.884 | nHRing | 1 |
| Solubility: LogP | -2.699 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 14.0516 |
| nHD | 2 | BPOL | 8.46045 |
| QED | 0.465 |
| Synth | 2.736 |
| Natural Product Likeliness | 1.288 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.14 |
| CACO-2 | -5.812 |
| MDCK | 0.0000866 |
| BBB | 0.488 |
| PPB | 0.116987 |
| VDSS | 0.677 |
| FU | 0.956911 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.424 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.284 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.02 |
| CL | 5.356 |
| T12 | 0.646 |
| hERG | 0.013 |
| Ames | 0.021 |
| ROA | 0.042 |
| SkinSen | 0.305 |
| Carcinogencity | 0.193 |
| EI | 0.348 |
| Respiratory | 0.268 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.98087 |